Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
Intern Med J
; 2022 Nov 27.
Article
in English
| MEDLINE | ID: covidwho-2136892
ABSTRACT
Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Prognostic study
Topics:
Vaccines
/
Variants
Language:
English
Journal subject:
Internal Medicine
Year:
2022
Document Type:
Article
Affiliation country:
Imj.15954
Similar
MEDLINE
...
LILACS
LIS